← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cerus Corporation
Concord, CA
$32,992,083
Total funding
19
Grants
Funding over time
peak $21.7M · FY2005–11$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
DOD$25,204,213 · 4
NIH$7,787,870 · 15
By mechanism
—$25,204,213 · 4
U01$4,127,085 · 2
R44$1,685,159 · 2
R43$1,259,626 · 8
R01$516,000 · 1
R42$100,000 · 1
Investigators at Cerus Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
CONTINUED INVESTIGATIONS OF NEW TECHNIQUES TO IMPROVE THE SAFETY AND AVAILABILITY OF BLOOD IN THE ARMED FORCES$19,159,213
· FY2008 · Department of Defense
PATHOGEN INACTIVATION OF RED BLOOD CELLS FOR HUMAN TRANSFUSION$2,546,000
· FY2008 · Department of Defense
ADVANCED DEVELOPMENT OF THE S-303 PATHOGEN INACTIVATION SYSTEM FOR RED BLOOD CELL COMPONENTS FOR TRANSFUSION AND WHOLE BLOOD$2,098,000
· FY2011 · Department of Defense
Psoralen-Killed, Metabolically-Active Anthrax Vaccine$1,461,608
U01 · FY2004 · AI
ADVANCED DEVELOPMENT OF PATHOGEN INACTIVATION TECHNOLOGY USING S-303 FOR RED BLOOD CELL COMPONENTS$1,401,000
· FY2010 · Department of the Army
Psoralen-Killed, Metabolically-Active Anthrax Vaccine$1,174,248
U01 · FY2005 · AI
Psoralen-Killed, Metabolically-Active Anthrax Vaccine$946,796
U01 · FY2006 · AI
Listeria Immunotherapy for Pancreatic and Ovarian Cancer$503,783
R44 · FY2005 · CA
Validation of Amotosalen-HCI for Clinical Use$374,303
R44 · FY2004 · HL
Validation of Amotosalen-HCI for Clinical Use$374,303
R44 · FY2005 · HL
Development of Listeria-Based Clinical Consensus HCV Vaccine Candidates$356,163
U01 · FY2006 · AI
Listeria Immunotherapy for Pancreatic and Ovarian Cancer$332,770
R44 · FY2006 · CA
Listeria-Based Ovarian Cancer Polyepitope Vaccines$279,813
R43 · FY2005 · CA
Listeria-Based Ovarian Cancer Polyepitope Vaccines$279,813
R43 · FY2006 · CA
STEM CELL TRANSPLANTATION WITH S-59 PHOTOCHEMICALLY TREA$258,000
R01 · FY2001 · HL
STEM CELL TRANSPLANTATION WITH S-59 PHOTOCHEMICALLY TREA$258,000
R01 · FY2000 · HL
Development of Listeria-Based Clinical Consensus HCV Vaccine Candidates$188,270
U01 · FY2007 · AI
Cord Blood Stem Cell Transplantation, Hemoglobinopathies$100,000
R43 · FY2003 · HL
Vaccine-enhanced DLI to prevent cancer recurrence after stem cell transplantation$100,000
R41 · FY2006 · HL
Listeria-Based Vaccines for Ovarian Cancer Therapy$100,000
R43 · FY2003 · CA